Developing the ATX(N) classification for use across the Alzheimer disease continuum
Year: 2021
Type: review
Source: Nature Reviews Neurology
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G1035719407, The Natural History of Cognitive Decline in Chronic Kidney Disease: Renal, Vascular and Alzheimer's Disease Contributions, Efficacy and Mechanisms of Combined Aerobic Exercise and Cognitive Training in MCI, Aerobic Exercise in Alzheimer's Disease Cognition and Hippocampal Volume Effects, Alzheimer's dementia onset and progression in international cohorts (Amended), G1959578664, The ARIC-PET Amyloid Imaging Study, Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors, Early Onset AD Consortium - the LEAD Study (LEADS), DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY, Alzheimers Disease Patient Registry, Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease, Clinicopathologic and Neuroimaging Differences in Alzheimer's Disease Variants, Alzheimer's Prevention Initiative ADAD Colombia Trial, Sphingolipids and Inflammation in the Development and Progression of Alzheimer's, Hearing loss, brain aging, and speech-in-noise performance in the ACHIEVE study, Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study, Mobility Decline: Relations to Cerebral Perfusion, Small Vessel Disease Progression, and Longitudinal Blood Pressure Exposures, Reproductive risk factors for Alzheimer's disease dementia and pathology, Combination anti-amyloid therapy for preclinical Alzheimer's disease, The ARIC study of midlife sleep and late-life brain amyloid, G691519165, The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease, Development, Validation, and Application of an Imaging based CVD Scale, The Role of Intracranial Atherosclerosis in the Development of Alzheimer's Disease, Brain Aging and Alzheimer's Biomarker Classification Using Amyloid PET, tau PET, and Neurodegeneration on MRI: Developing the ATN system, DIAN-TU: Next Generation Prevention Trial, Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission, Disease pathways in the population determined by amyloid, tau, and neurodegeneration imaging biomarkers, Investigating Resistance and Resilience Mechanisms in Alzheimer’s Disease, Alzheimer's Clinical Trials Consortium (ACTC), ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028, Alzheimer's Disease Neuroimaging Initiative (ADNI4), Mayo Alzheimer's Disease Research Center, Synucleinopathies – Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic Approach, SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging, US POINTER Neuroimaging Ancillary Study
OpenAlex ID: W3182597378
